Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma

Clinical trial NCT02565173 · COMPLETED

Trial details

NCT number: NCT02565173
Sponsor: Inotek Pharmaceuticals Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Start date: 2015-09-01
Primary completion: 2016-11-01
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.